Natural Products Potential and Scope for Modern Cancer Research

Abstract

In the present time Natural products are considered to be symbols of protection in comparison to the synthetic product that are regarded as unsafe to human life and environment. Although a large number of synthetic drugs are being added to the world of present pharmacopoeia, but still no system of medicine in the world has been able to solve all the health problems, which include diseases like Cancer. Therefore the search for innovative therapeutic constituents from plants is genuine and urgent. In India, there is an ocean of knowledge about medicinal plants and rich medicinal flora, but still only a few pearls have been searched as therapeutic agents. There are large numbers of original plants left which have not been investigated thoroughly from modern scientific view or their healing values have not been known. Thus there is an insistent need for systematic phytochemical examination of those plants which have not been investigated scientifically. More research can be done to investigate the unknown and unexplored potential of plants. Further analysis of plants (active compounds) can be carried out by way of making use of different analytical methods such as HPTLC, HPLC, NMR and UV spectrophotometer analysis or computer based drug designing.

Share and Cite:

R. Nema, S. Khare, P. Jain, A. Pradhan, A. Gupta and D. Singh, "Natural Products Potential and Scope for Modern Cancer Research," American Journal of Plant Sciences, Vol. 4 No. 6, 2013, pp. 1270-1277. doi: 10.4236/ajps.2013.46157.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] J. S. Bertram, “The Molecular Biology of Cancer,” Molecular Aspects of Medicine, Vol. 21, No. 6, 2001, pp. 167-223. doi:10.1016/S0098-2997(00)00007-8
[2] National Cancer Institute, 2009. www.cancer.gov/
[3] M. A. Indap, S. Radhika, L. Motiwale and K. V. K. Rao, “Quercetin: Antitumor Activity and Pharmacological Manifestations for Increased Therapeutic Gains,” Indian Journal of Pharmaceutical Sciences, Vol. 68, No. 4, 2006, pp. 465-469. doi:10.4103/0250-474X.27819
[4] J. B. Kim, H. N. Koo and H. J. Yoeng, “Introduction of Apoptosis by Korean Medicine Gagam-Whanglyun-Haedoktang through Activation of Capase-3 in Human Leukemia Cell Line, HL-60 Cells,” Journal of Pharmacological Sciences, Vol. 97, No. 1, 2005, pp. 138-145. doi:10.1254/jphs.FPJ04021X
[5] P. J. Mathew and C. M. Unnithan, “Search for Plants Having Anti-Cancer Properties Used by the Tribals of Wayanad, Malappuram and Palakkad Districts of Kerala, India,” Aryavaidyan, Vol. 6, No. 1, 1992, pp. 61-67.
[6] S. Perumal and S. Ignacimuthu, “Screening of 34 Indian Medicinal Plants for Antibacterial Properties,” Journal of Ethnopharmacology, Vol. 62, No. 2, 1998, pp. 173-182. doi:10.1016/S0378-8741(98)00057-9
[7] C. Kirana, G. H. McIntosh, I. R. Record and G. P. Jones, “Antitumor Activity of Extract of Zingiber aromaticum and Its Bioactive Sesquiterpenoid Zerumbone,” Nutrition and Cancer, Vol. 45, No. 2, 2003, pp. 218-225. doi:10.1207/S15327914NC4502_12
[8] P. J. Ferguson, E. Kurowska, D. J. Freeman, A. F. Chambers and D. J. Koropatnick, “A Flavonoid Fraction from Cranberry Extract Inhibits Proliferation of Human Tumor Cell Lines,” Journal of Nutrition, Vol. 134, No. 6, 2004, pp. 1529-1535.
[9] G. M. Cragg and D. J. Newman, “Plant as a Source of Anticancer Agent,” Journal of Ethnopharmacology, Vol. 100, No. 1-2, 2005, pp. 72-79. doi:10.1016/j.jep.2005.05.011
[10] S. I. Kintzios, G. Marinopoulou, O. Moschopoulou, K. Mangana, K. Nomikou, K. Endo, I. Papanastasiou and A. Simonian, “Construction of a Novel, Multi-Analyte Biosensor System for Assaying Cell Division,” Biosensors and Bioelectronics, Vol. 21, No. 7, 2006, pp. 1365-1373. doi:10.1016/j.bios.2005.04.022
[11] A. A. Fali and M. Mocker, “Overview of Plant Drived Anticancer Drug,” International Journal of Biomedical Sciences, Vol. 5, No. 1, 2009, pp. 1-11.
[12] H. T. Wamidh and M. M. Adel, “Antimicrobial, Cytotoxicity and Phytochemical Screening of Jordanian Plants Used in Traditional Medicine Molecules, Vol. 15, No. 3, 2010, pp. 1811-1824.
[13] W. M. Gesler, “Therapeutic Landscape: Medicinal Issue in Light of the New Cultural Geography,” Social Science & Medicine, Vol. 34, No. 7, 1992, pp. 735-746. doi:10.1016/0277-9536(92)90360-3
[14] W. Talib and A. Mahasneh, “Antiproliferative Activity of Plant Extracts Used against Cancer in Traditional Medicine,” Scientia Pharmaceutica, Vol. 78, No. 1, 2012, pp. 33-45. doi:10.3797/scipharm.0912-11
[15] P. V. Sharma and S. Charaka, “Choukhamba Orientalia, Vol. 5,” Choukhamba Bharti Academy, Varanasi, 1981.
[16] K. L. Bhishagratha and S. Sushruta, “Choukhamba Orientalia,” Choukhamba Bharti Academy, Varanasi, 1991, pp. iii-lxvi (I), i-xvii (II).
[17] G. C. Prasad, “Studies on Cancer in Ayurveda and Its Management,” Journal of Research in Science, Vol. 3, No. 4, 1987, pp. 147-167.
[18] R. M. Singh, “An Assessment of Ayurvedic Concept of Cancer and a New Paradigm of Anticancer Treatment in Ayurveda,” Journaal of Cancer Medicine, Vol. 8, No. 5, 2002, pp. 609-694.
[19] L. H. Breimer, “Molecular Mechanisms of Oxygen Radical Carcinogenesis and Mutagenesis: The Role of DNA Base Damage,” Molecular Carcinogenesis, Vol. 3, No. 4, 1990, pp. 188-197. doi:10.1002/mc.2940030405

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.